Showing results (51-60 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|June 24, 2020
Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective studyBurak Kömürcü, Elif Tükenmez Tigen, Tayfur Toptaş, et al.Expert Review of Hematology|April 16, 2020
Newly diagnosed multiple myeloma: current treatment strategies, emerging therapeutic approaches and beyondMehmet H Kocoglu, Ashraf Z BadrosExpert Review of Hematology|April 16, 2020
Monoclonal antibodies in newly diagnosed and smoldering multiple myeloma: an updated review of current clinical evidencePellegrino Musto, Francesco La RoccaExpert Review of Hematology|September 8, 2021
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategiesAli T Taher, Rayan Bou-Fakhredin, Antonis Kattamis, et al.Expert Review of Hematology|September 6, 2021
Chronic neutropenia: how best to assess severity and approach management?Jean Donadieu, Stephanie Frenz, Lauren Merz, et al.Expert Review of Hematology|May 12, 2015
Bronchial myeloid sarcoma with concurrent Aspergillus fumigatus infection in a patient presenting with hemoptysisAdarsh Vennepureddy, Gautam Valecha, Srujitha Murukutla, et al.Expert Review of Hematology|May 8, 2015
Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi ProvinceHua Zhao, Linhua Yang, Chao Long, et al.Expert Review of Hematology|April 11, 2020
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic proceduresWilma Barcellini, Juri Giannotta, Bruno FattizzoExpert Review of Hematology|August 5, 2021
New approaches to managing relapsed/refractory Hodgkin lymphoma: the role of checkpoint inhibitors and beyondJessica Caro, Catherine DiefenbachExpert Review of Hematology|June 25, 2020
The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia - are we ready for chemo-free immunotherapy approach?Vibor Milunović, Karla Mišura Jakobac, Inga Mandac Rogulj, et al.Pageof 157